Use access key #2 to skip to page content.
$4.29 0.79 (22.57%)
11/21/2008 4:08 PM

Enzo Biochem, Inc. (ENZ)

CAPS Rating:
***

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ENZ

Add Stock to Watchlist

What the Community Thinks

Total Members

45 Outperforms
9 Underperforms
 

All-Stars

8 Outperforms
2 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on ENZ are also bullish on:

Members bearish on ENZ are also bearish on:

Ticker Tags

Research (14), Life Sciences Tools and Services (59), Micro Cap (5043)
Suggest a tag

Enzo Biochem, Inc. At A Glance

Current Price: $4.29
Last Trade Time: 11/21/2008 4:08 PM
Open: $3.58
Previous Close: $3.50
Daily Range: $3.36 - $4.31
52-Week Range: $3.49 - $14.90
Volume: 302,286
Market Cap: $130.84M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ENZ VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ENZ

More Headlines...

Top Bull Pitch

Recs

1

Enzo Biochem, Inc. (ENZ)

Avatar trm3 (< 20) Submitted: 9/10/08 2:54 PM

pwr 10

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 11 :   1 2 3 Next »

Recs

0

 (ENZ)

Avatar zzlangerhans (99.48) Submitted: 11/08/08 8:02 PM : Outperform Start Price: $6.17 ENZ Score: -10.16

Enzo stock seems to have stabilized from its recent precipitous decline. The severity of the drop is only matched in mysteriousness by the ascent to 15 over the summer without any clear precipitant. My main complaint about Enzo remains the same - slow progress in the pipeline with confusing guidance about expected timing of completion of trials. However, it is hard to ignore a company generating 20M of revenue per quarter at this market cap, even though they continue to operate at a slight loss. I think Enzo may trade range-bound for a while, and is likely at the lower end of range now. Of course, nothing the stock has done has made sense for a year, so why am I still writing this pitch?

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ENZ)

Avatar trm3 (< 20) Submitted: 9/10/08 2:54 PM : Outperform Start Price: $11.23 ENZ Score: -22.84

pwr 10

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZ)

Avatar MC40 (79.10) Submitted: 8/23/08 9:09 PM : Outperform Start Price: $13.64 ENZ Score: -27.41

They're makin' money.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZ)

Avatar marv818 (< 20) Submitted: 12/24/07 10:32 PM : Outperform Start Price: $14.40 ENZ Score: -21.22

The company will be sold within several months

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZ)

Avatar MM4L (66.86) Submitted: 9/07/07 6:22 PM : Outperform Start Price: $12.70 ENZ Score: -17.98

Okay, Enzo took their hit and lost $5 in one day. At $12.56, they are a good value stock in a good bio-tech player, looking to rebound. If they win the litigation, they will pop up over $18.. maybe $20.





Let's get real. They have over 200 patents and 180 more pending. This is THEM suing others for infringment.. it is not like THEY were the ones infringing. I find it hard to believe 25-30% of their value was solely based upon this suit and it's outcome.





I think if you were a previous "inderperform" voter, now would be a good time to see that this stock has corrected and is due to head upward from here, at tleast doe the next 1-2 years.





I see this stock hitting $15-16 in the next 3-6 months. You can wait and watch or pan the stock and miss out on the upward movement.





I'm in for 500 shares at $12.58.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 11 :   1 2 3 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLazardCapit < 20 09/13/07 Outperform NS $11.94-64.07%-49.03%-15.04

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links